NON-INTERVENTIONAL STUDIES. 13.1 Non-Interventional Studies (“NISs”) must address a scientifically and medically valid question to which the Company needs the answer. These may include: the effectiveness and/or safety of a Company Product, medical practice and drug utilisation characterisation, disease epidemiology and clinical epidemiology, burden of disease (e.g., costs and quality of life) or other Patient-reported outcomes, and compliance/adherence to a therapeutic regimen.
Appears in 5 contracts
Samples: Development and Commercialization Agreement (Fibrogen Inc), License, Development and Commercialization Agreement, Development and Commercialization Agreement (Fibrogen Inc)
NON-INTERVENTIONAL STUDIES. 13.1 Non-Interventional Studies (“NISs”) must address a scientifically and medically valid question to which the Company needs the answer. These may include: the effectiveness and/or safety of a Company Product, medical practice and drug utilisation characterisation, disease epidemiology and clinical epidemiology, burden of disease (e.g., costs and quality of life) or other Patient-reported outcomes, and compliance/adherence to a therapeutic regimen.
Appears in 1 contract
Samples: Fibrogen Inc